← 홈

Antibody

136개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-14 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 136개
AntibodyHotRochederuxtecan (Dato-DXd, Datro…Approved

trastuzumab (Herceptin)

Non Small Cell Lung Cancer; Colorectal Cancer · Metastatic Salivary Gland Carcinoma

#MetastaticSalivaryGlandCarcinoma#Antibody#Approved#인기#항체+5
효능 ORR 91.8%임상시험 676상태 RECRUITING
AntibodyCHotRocheDM1) and trastuzumab deruxt…Phase 3

Pertuzumab (Pertuzumab)

Colorectal Cancer · HER2

#HER2#Antibody#Phase3#인기#항체+5
효능 ORR 91.8%임상시험 204상태 DISCONTINUED
AntibodyBHotMerck KGaAvedotin (EV) was the most c…Phase 3

Avelumab (Avelumab)

Non Small Cell Lung Cancer; Colorectal Cancer · Locally Advanced or Metastatic Urothelia

#LocallyAdvancedorMetastaticUroth#Antibody#Phase3#인기#항체+5
효능 ORR 74%임상시험 105상태 ACTIVE
AntibodyCBeiGeneVedotin, Tislelizumab, and …Phase 2

Tislelizumab (Tislelizumab)

Locally Recurrent Colorectal Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#Antibody#Phase2#인기#항체+5
효능 ORR 37.1%임상시험 96상태 RECRUITING
AntibodyCJunshi Biosciencesvedotin (EV) in combination…Phase 3

Toripalimab (Toripalimab)

Metastatic Colorectal Cancer; Liver Metastases · Gastric Cancer

#GastricCancer#Antibody#Phase3#인기#항체+5
임상시험 93상태 RECRUITING
AntibodyARochePhase 3

atezolizumab (Tecentriq, MPDL3280A, Atezolizumab (MPDL3280A), an Engineered Anti-PDL1 Antibody)

Triple-Negative Breast Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#인기#항체+4
효능 ORR 76.7%임상시험 90상태 ACTIVE
AntibodyAAmgenPhase 3

Panitumumab (Panitumumab)

Colorectal Cancer; Resectable Colorectal Carcinoma · Head and Neck Squamous Cell Carcinoma

#HeadandNeckSquamousCellCarcinoma#Antibody#Phase3#인기#항체+5
효능 ORR 77.3%임상시험 83상태 RECRUITING
AntibodySun Yat-sen Universityvedotin combined with immun…Phase 3

Serplulimab (Serplulimab)

Colorectal Cancer; Liver Metastases · Solid Tumor Cancer

#SolidTumorCancer#Antibody#Phase3#인기#항체+5
임상시험 60상태 RECRUITING
AntibodyJanssenderuxtecan, datopotamab der…Phase 3

Amivantamab (Amivantamab)

Carcinoma, Non-Small-Cell Lung · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#인기#항체+5
효능 ORR 4.3%임상시험 51상태 RECRUITING
AntibodyGruppo Oncologico del Nord-OvestPhase 2

Balstilimab (Balstilimab)

Colorectal Cancer; Resectable Colorectal Carcinoma · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+3
임상시험 45상태 RECRUITING
AntibodyGruppo Oncologico del Nord-OvestPhase 2

Botensilimab (Botensilimab)

Colorectal Cancer; Resectable Colorectal Carcinoma · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+3
임상시험 38상태 RECRUITING
AntibodyEli LillyPhase 2

Cetuximab + mFOLFOX6 (Cetuximab + mFOLFOX6)

Neoadjuvant Treatment; Rectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#항체#면역항체+4
효능 ORR 55%임상시험 31상태 RECRUITING
AntibodystaleGilead SciencesPhase 2

Magrolimab (Magrolimab)

Solid Tumor; Colorectal Cancer · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#항체#면역항체+4
효능 ORR 66.7%임상시험 30상태 DISCONTINUED
AntibodystaleRochePhase 2

trastuzumab (Herceptin, Trastuzumab, Lapatinib)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#항체#면역항체+2
효능 ORR 50%임상시험 30상태 ACTIVE
AntibodystaleRochePhase 2

CapeOX + bevacizumab (CapeOX + bevacizumab)

Unresectable Metastatic Colorectal Cancer; Microsatellite Stable (MSS) Colorectal Cancer (CRC) · Rectal Cancer

#RectalCancer#Antibody#Phase2#항체#면역항체+4
임상시험 25상태 RECRUITING
AntibodyJanssenPhase 2

Amivantamab + FOLFIRI (Amivantamab + FOLFIRI)

RAS/BRAF Wild-type Advanced Colorectal Cancer Patients · RAS/BRAF Wild-type Advanced Colorectal C

#RASBRAFWild-typeAdvancedColorect#Antibody#Phase2#항체#면역항체+4
임상시험 4상태 RECRUITING
AntibodystaleEli LillyPhase 2

Cetuximab + Irinotecan (Cetuximab + Irinotecan)

Advanced Colorectal Cancer · FRα

#FR#Antibody#Phase2#항체#면역항체+3
효능 ORR 2.081%임상시험 2상태 ACTIVE
AntibodystaleEli LillyPhase 3

Cetuximab, Capecitabine (Cetuximab, Capecitabine)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 2상태 ACTIVE
AntibodystaleRochePhase 3

China-approved Bevacizumab (China-approved Bevacizumab)

Metastatic Colorectal Cancer (CRC) · Advanced Non-squamous Non-small-cell Lun

#AdvancedNon-squamousNon-small-ce#Antibody#Phase3#항체#면역항체+3
임상시험 2상태 ACTIVE
AntibodystaleRocheApproved

Oxaliplatin;Capecitabine;Bevacizumab (Oxaliplatin;Capecitabine;Bevacizumab)

Colorectal Cancer; Liver Metastases · Gastric Cancer

#GastricCancer#Antibody#Approved#항체#면역항체+4
임상시험 2상태 ACTIVE

1 / 7 페이지

← 이전다음 →